The recent press release about the design of the first-ever functional 3D splenon capable of reproducing the function of the spleen, which is to filter red blood cells, by researchers from IBEC and CRESIB received lots of media coverage. Below are just a few examples.
Last week’s press release about the Biomedical Signal Processing and Interpretation group’s new non-invasive method to monitor patients with respiratory diseases has been covered in the health section of Spanish national daily newspaper ABC.
The news about Xavier Trepat’s Proof of Concept grant from the ERC appears in La Vanguardia today.
IBEC is mentioned in the press today in relation to the HYPER project, of which the Robotics group is a partner. The story reveals the start of some pilot tests with real spine patients at the Hospital Nacional de Parapléjicos de Toledo with the robots being developed by the project, which aims to develop new treatments in neurorehabilitation and help with patients’ mobility.
IBEC Director Josep Samitier stars in one of the Associació per a la Divulgació de la Cultura Cientifica (ADICC)’s ‘Càpsules de Ciència’, a series of videos highlighting biomedical and biotechnology researchers in Catalonia. In the video, he explains nanobiotechnology with the submarine on Ronda de Dalt as a backdrop, which represents the way nanodevices can travel through our bodies much like tiny submarines on a rescue mission.
At the end of last year El Periódico covered the Biomaterials for Regenerative Therapies group’s crowdfunding venture, the Dermoglass project, with a full page article and colour photos.
This week’s press release about the Integrative Cell and Tissue Dynamics group’s work published in Nature Materials has appeared online in La Vanguardia, ABC and El Diario.
Josep Samitier, Xavier Fernandez-Busquets, Santiago Marco and Sergio Oller all feature in this half-hour episode of science programme ‘El problema de Gettier’, which is devoted to nanotechnology.
Last week BTV’s Connexió programme reported on three of the projects which are currently raising funds by crowdfunding under the UPC’s SUMA initiative. One is the Biomaterials for Regenerative Therapies … Read more